Tasigna Atherosclerosis Lawsuit News

Who Can Be Considered A Tasigna Victim

Thousands of Americans may be able to file an individual lawsuit against Novartis, maker of the deadly anti-cancer drug Tasigna

Friday, August 4, 2017 - As a person who has been the victim of Novartis AG's negligence in marketing the anti-leukemia drug Tasigna for chemotherapy treatments, you may join the thousands of others just like you and sue the company in order to gain reimbursement for your expenses and also to hold them responsible for their actions. Filing a lawsuit can not only compensate you for your expenses and pain and suffering but also alert others to stop using the drug. Novartis AG put profits ahead of public safety when marketing executives deliberately failed to warn the American public of the deadly side effects of Tasigna.

In 2013, the Canadian Health officials issued a warning that Tasigna causes atherosclerosis, but rather than alert American cancer oncologists that patients on Tasigna risk sudden death from heart attack, stroke and other atherosclerosis-related conditions the company chose to double down and increase the financial incentives to American doctors to prescribe Tasigna cancer treatments. As a result of their ignorance of the deadly side effects of Tasigna, American doctors continued to use the drug for years and now thousands of innocent Americans are at risk of instant death from heart attacks and strokes. Other victims of Novartis are reporting that they have had to have a limb amputated because their atherosclerosis went undiagnosed as just common symptoms of chemotherapy, and caused necrosis of the tissues at the tips of the body's extremities.

Tasigna is now required to carry a "Black Box" health warning to alert physicians to actively monitor Tasigna cancer patients for heart abnormalities. If you are undergoing chemotherapy using the Tasigna you are at an increased risk for developing atherosclerosis and peripheral artery disease, deadly conditions that can cause sudden death. It is advisable to immediately seek medical attention and have an ECG performed specifically to ascertain the extent of the blockages in your arteries that may have already occurred.

Each Tasigna lawsuit is unique and handled individually. Due to the high number of individuals suing Novartis over Tasigna, multi-district litigation has started to avoid duplication of discovery and to speed the time of each case to trial. Multi-district litigation is not a class action, it is simply a tool to make your lawsuit more efficient and effective. Each case is dealt with individually and stands on its own merit and the compensatory and punitive damages you can receive are based on your expenses and suffering.

If you are using Tasigna and have been diagnosed with rapid-onset atherosclerosis or if you have a loved one who has died from the condition, our Tasigna lawsuit attorneys will represent you on a contingency basis. This means that there is no up front legal fees and you only pay if we win and collect. The size, scope, and resources of our firm, as well as our history of success suing large medical-related companies like Johnson & Johson, give us a leg up on our competition.

More Recent Tasigna Atherosclerosis Lawsuit News:

Lawyers for Tasigna Atherosclerosis Lawsuits

Attorneys handling Tasigna lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Tasigna lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Tasigna lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.